{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:24:09Z","timestamp":1780359849882,"version":"3.54.1"},"reference-count":20,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2017,4,17]],"date-time":"2017-04-17T00:00:00Z","timestamp":1492387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0175478","type":"journal-article","created":{"date-parts":[[2017,4,17]],"date-time":"2017-04-17T13:32:02Z","timestamp":1492435922000},"page":"e0175478","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1233-6981","authenticated-orcid":true,"given":"Alfred L.","family":"Yergey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Cologna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Backlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forbes D.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan J.","family":"Darling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,4,17]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1517\/17425247.2.1.335","article-title":"Cyclodextrins in drug delivery","volume":"2","author":"T Loftsson","year":"2005","journal-title":"Expert Opin Drug Deliv"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"26907","DOI":"10.1038\/srep26907","article-title":"Cholesterol depletion from a ceramide\/cholesterol mixed monolayer: a Brewster angle microscope study","volume":"6","author":"P Mandal","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"ref3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10545-014-9794-4","article-title":"Complex lipid trafficking in Niemann-Pick disease type C","volume":"38","author":"MT Vanier","year":"2015","journal-title":"J Inherit Metab Dis"},{"issue":"9","key":"ref4","doi-asserted-by":"publisher","first-page":"e6951","DOI":"10.1371\/journal.pone.0006951","article-title":"Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression","volume":"4","author":"CD Davidson","year":"2009","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/1750-1172-8-166","article-title":"Niemann-Pick disease type C symptomatology: an expert-based clinical description","volume":"8","author":"E Mengel","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"ref6","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/acn3.306","article-title":"Efficacy and ototoxicity of different cyclodextrins in Niemann-Pick C disease","volume":"3","author":"CD Davidson","year":"2016","journal-title":"Ann Clin Translat Neurol"},{"issue":"2","key":"ref7","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1016\/j.ymgme.2015.12.411","article-title":"Phase 1\/2 evaluation of intrathecal 2-hydroxypropyl-beta-cyclodextrin for the treatment of Niemann-Pick disease type C1 [abstract]","volume":"117","author":"FD Porter","year":"2016","journal-title":"Mol Genet Metab"},{"key":"ref8","unstructured":"Zavesca [package insert]. South San Francisco, CA: Actelion Pharmaceuticals, Inc.; 2016 February 2016."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jns.2016.04.048","article-title":"Use of 2 hydroxypropyl-beta-cyclodextrin therapy in two adult Niemann Pick Type C patients","volume":"366","author":"AA Garcia-Robles","year":"2016","journal-title":"J Neurol Sci"},{"issue":"3","key":"ref10","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1177\/1756285616635964","article-title":"Diagnostic workup and management of patients with suspected Niemann-Pick type C disease","volume":"9","author":"A Papandreou","year":"2016","journal-title":"Ther Adv Neurol Disord"},{"issue":"4","key":"ref11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1203\/PDR.0b013e3181ee4dd2","article-title":"Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life","volume":"68","author":"CM Ramirez","year":"2010","journal-title":"Pediatr Res"},{"issue":"276","key":"ref12","article-title":"Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease","volume":"7","author":"CH Vite","year":"2015","journal-title":"Sci Transl Med"},{"key":"ref13","unstructured":"Study of VTS-270 (2-hydroxypropyl-beta-cyclodextrin) to treat Niemann-Pick type C1 (NPC1) disease NCT02534844: ClinicalTrials.gov. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02534844\" xlink:type=\"simple\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02534844<\/ext-link>. Accessed March 1, 2017."},{"issue":"12","key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21121748","article-title":"Cyclodextrins as emerging therapeutic tools in the treatment of cholesterol-associated vascular and neurodegenerative diseases","volume":"21","author":"C Coisne","year":"2016","journal-title":"Molecules"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0378-5173(86)90201-2","article-title":"Hydroxypropyl-B-cyclodextrin: preparation and characterization; effects on solubility of drugs","volume":"29","author":"J Pitha","year":"1986","journal-title":"Int J Pharm"},{"issue":"5","key":"ref16","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1021\/cr970019t","article-title":"NMR studies of cyclodextrins and cyclodextrin complexes","volume":"98","author":"HJ Schneider","year":"1998","journal-title":"Chem Rev"},{"key":"ref17","unstructured":"Hydroxypropyl betadex certificate: U.S. Pharmacopeial Convention; 2016. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/static.usp.org\/pdf\/EN\/referenceStandards\/certificates\/1329709-F0B295.pdf\" xlink:type=\"simple\">http:\/\/static.usp.org\/pdf\/EN\/referenceStandards\/certificates\/1329709-F0B295.pdf<\/ext-link>. Accessed March 1, 2017."},{"issue":"20","key":"ref18","doi-asserted-by":"publisher","first-page":"6824","DOI":"10.1039\/C5AN00923E","article-title":"Broadscale resolving power performance of a high precision uniform field ion mobility-mass spectrometer","volume":"140","author":"JC May","year":"2015","journal-title":"Analyst"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/3527602852","article-title":"Transport properties of ions in gases","author":"EA Mason","year":"1988"},{"key":"ref20","unstructured":"Kurulugama R, Imatani K, Taylor L. The Agilent Ion Mobility Q-TOF Mass Spectrometer System: Technical Overview. Santa Clara, CA: Agilent Technologies; 2013. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.agilent.com\/cs\/library\/technicaloverviews\/public\/5991-3244EN.pdf\" xlink:type=\"simple\">https:\/\/www.agilent.com\/cs\/library\/technicaloverviews\/public\/5991-3244EN.pdf<\/ext-link>. Accessed March 1, 2017."}],"updated-by":[{"DOI":"10.1371\/journal.pone.0192424","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0175478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:22:31Z","timestamp":1540340551000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0175478"}},"subtitle":[],"editor":[{"given":"Matej","family":"Ore\u0161i\u010d","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,4,17]]},"references-count":20,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0175478","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727513588.793542552","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,17]]}}}